Steady Expansion Forecast for Bilirubin Blood Test Market, Projected to Reach $1.94 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Bilirubin Blood Test Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the bilirubin blood test market has experienced substantial growth. The market is predicted to expand from its size of $1.37 billion in 2024, reaching $1.46 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.9%. Various factors have contributed to the growth in the preceding years, including a higher prevalence of liver diseases, advances in neonatal care, technological progress, heightened awareness about health, development of healthcare infrastructure, regulatory authorizations and directives, and a rising trend in point-of-care testing.

Bilirubin Blood Test Market Size Forecast: What's the Projected Valuation by 2029?
In the upcoming years, the market size for bilirubin blood tests is predicted to experience a significant increase. The projected growth will reach $1.94 billion by 2029, displaying a compounded annual growth rate (CAGR) of 7.4%. This growth during the forecast period can be linked to a growing need for early diagnostic procedures, the broadening reach of diagnostic laboratories, increasing prevalence of chronic diseases, expanding markets, incorporation of high-level analytics, and an up surge in research funding. Trends to watch in the forecast period include the advent of non-invasive test procedures, merging with digital health solutions, improvements in at-home testing kits, enhanced accuracy and speed in testing, personalized treatment methodologies, intelligent diagnostic tools, and the emergence of portable devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

What Are the Drivers Transforming the Bilirubin Blood Test Market?
An upswing in the cases of liver diseases is anticipated to spur the expansion of the bilirubin blood test market in the future. These diseases can hinder the liver's optimal performance and can stem from various factors like infections, excessive intake of alcohol, or metabolic issues. The increase in liver disease instances is directly linked to the escalating obesity rates, overconsumption of alcohol, viral infections, and poor lifestyle decisions that collectively lead to liver malfunction and damage. Significant changes in the bilirubin levels in the body can be caused by liver disease, making bilirubin blood tests instrumental in diagnosing and monitoring liver function, offering key findings about patient health and assisting medical professionals in effectively managing and combating liver-related conditions. For example, in April 2024, the European Centre for Disease Prevention and Control, a health agency based in Sweden, recorded 28,855 hepatitis B virus (HBV) infection cases across 30 EU/EEA Member States in 2022, marking a 78% increase from 16,187 cases in 2021. Furthermore, the total number of cases in 2022, coming in at 28,420, embodies a crude rate of 8.5 cases per 100,000 individuals. As a result, the increasing instances of liver diseases are fuelling the growth of the bilirubin blood test market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

What Long-Term Trends Will Define the Future of the Bilirubin Blood Test Market?
Major businesses in the bilirubin blood test market are leveraging strategic partnerships to broaden their scope and improve their services. Essentially, a strategic partnership involves two or more organizations pooling their resources, know-how and efforts to attain mutual goals. For example, Calmark Sweden AB, a biotech company providing medical diagnostic solutions from Israel, entered into an exclusive distributor contract with Techno Orbits in Saudi Arabia for Calmark's bilirubin test for infants in December 2023. The distribution and sales of the product will be managed by Techno Orbits, benefiting from its established network and affiliations, including those with the Ministry of Health. The objective of this alliance is to aid the launch of Calmark's bilirubin test in the Saudi market, with the anticipation of regulatory registration within a 3 to 6 months timeframe.

Which Segments in the Bilirubin Blood Test Market Offer the Most Profit Potential?
The bilirubin blood test market covered in this report is segmented -

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test
2) By Age Group: Adults, Pediatrics, Infants
3) By Application: Hospital, Clinic, Other Applications

Subsegments:
1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection
2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert's Syndrome Detection, Monitoring For Preliver Conditions
3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Which Firms Dominate the Bilirubin Blood Test Market by Market Share and Revenue in 2025?
Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

Which Regions Offer the Highest Growth Potential in the Bilirubin Blood Test Market?
North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18522

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.